Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03049423 in Ischemic Stroke
NCT01208233Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of PF-03049423 in ischemic stroke, sponsored by Pfizer. Started Dec 2010; status: terminated.
02
Drugs
PF-03049423
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01208233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208233.